XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 45.18

Change

+0.17 (+0.38)%

Market Cap

CAD 0.55B

Volume

676.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.47 (+0.31%)

CAD 20.69B
ZSP:CA BMO S&P 500

+0.28 (+0.30%)

CAD 18.86B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.08 (+0.13%)

CAD 11.36B
VUN:CA Vanguard US Total Market

+0.26 (+0.23%)

CAD 11.07B
XUS:CA iShares Core S&P 500 Index ETF

+0.16 (+0.30%)

CAD 8.43B
HXS:CA Global X S&P 500 Corporate Cla..

+0.21 (+0.24%)

CAD 4.68B
VSP:CA Vanguard S&P 500 CAD hedged

+0.08 (+0.08%)

CAD 4.03B
QUU:CA Mackenzie US Large Cap Equity ..

+0.77 (+0.31%)

CAD 3.49B
XUU:CA iShares Core S&P US Total Mark..

+0.31 (+0.50%)

CAD 3.43B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.01 (+0.02%)

CAD 3.26B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.60% 70% C- 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.60% 70% C- 53% F
Trailing 12 Months  
Capital Gain 33.20% 88% B+ 85% B
Dividend Return 1.09% 28% F 12% F
Total Return 34.29% 86% B+ 84% B
Trailing 5 Years  
Capital Gain 97.81% 77% C+ 87% B+
Dividend Return 6.83% 17% F 12% F
Total Return 104.64% 75% C 85% B
Average Annual (5 Year Horizon)  
Capital Gain 14.95% 76% C+ 79% B-
Dividend Return 15.79% 73% C 76% C+
Total Return 0.85% 23% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 15.49% 37% F 55% F
Risk Adjusted Return 101.98% 64% D 95% A
Market Capitalization 0.55B 53% F 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.